Published 11 days ago • loading... • Updated 10 days ago

A New Milestone in Electronic Fetal Monitoring: FDA 510(k) Clearance Granted for Dawes-Redman CTG Analysis™

Summary by Longview News-Journal

ADDISON, Ill., March 24, 2025 /PRNewswire/ -- Huntleigh Healthcare is proud to announce that the world-renowned Dawes-Redman CTG Analysis™ has been approved for use in the U.S. by the Food and Drug Administration (FDA). This landmark achievement aims to assist…

2 Articles

All

Left

Center

Right

Longview News-Journal

Center

A New Milestone in Electronic Fetal Monitoring: FDA 510(k) Clearance Granted for Dawes-Redman CTG Analysis™

11 days ago

Read Full Article

Medical Device Network

FDA grants 510(k) clearance for Huntleigh’s CTG Analysis

The FDA has granted 510(k) approval for UK-based Huntleigh Healthcare’s Dawes-Redman CTG Analysis for foetal monitoring applications.The post FDA grants 510(k) clearance for Huntleigh’s CTG Analysis appeared first on Medical Device Network.

10 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center1Last Updated9 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Longview News-Journal broke the news in 11 days ago on Monday, March 24, 2025.

Sources are mostly out of (0)

A New Milestone in Electronic Fetal Monitoring: FDA 510(k) Clearance Granted for Dawes-Redman CTG Analysis™

2 Articles

2 Articles

A New Milestone in Electronic Fetal Monitoring: FDA 510(k) Clearance Granted for Dawes-Redman CTG Analysis™

FDA grants 510(k) clearance for Huntleigh’s CTG Analysis

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics